Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Galmed Pharmaceuticals Ltd. - Ordinary Shares (NQ: GLMD )

3.040 UNCHANGED
Streaming Delayed Price Updated: 12:55 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3
Open 3.040
Bid (Size) 2.920 (1)
Ask (Size) 3.320 (2)
Prev. Close 3.040
Today's Range 3.040 - 3.040
52wk Range 2.560 - 23.80
Shares Outstanding 6,358,747
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
A look at the most-searched tickers on Benzinga Pro for the month of October. Donald Trump and biotech stocks joined the top 10. 
Via Benzinga
Topics Government
Exposures Political
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
A look at the 20 most searched tickers on Benzinga Pro, which includes many familiar names and some penny stocks that may be less familiar. 
Via Benzinga

Performance

YTD
-42.37%
-42.37%
1 Month
+5.92%
+5.92%
3 Month
-57.12%
-57.12%
6 Month
-18.31%
-18.31%
1 Year
-41.09%
-41.09%

More News

Read More
MarketBeat Week in Review – 9/16 - 9/20
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
Via FinancialNewsMedia
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
From FN Media Group LLC
Via GlobeNewswire
Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why
Via Benzinga
US Stocks Mixed; General Mills Posts Upbeat Earnings
Via Benzinga
Why Intuitive Machines Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
Via MarketBeat
Gold Edges Lower; US Homebuilder Sentiment Rises For September
Via Benzinga
Crude Oil Gains Over 1%; US Business Inventories Increase In July
Via Benzinga
Exposures Fossil Fuels
Nasdaq Surges 100 Points; US Retail Sales Beat Estimates
Via Benzinga
Topics Earnings
Exposures Financial
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Mainz Biomed Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
GLMD Stock Earnings: Galmed Pharmaceuticals Reported Results for Q1 2024
Via InvestorPlace
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
Via InvestorPlace
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
GLMD Stock Earnings: Galmed Pharmaceuticals Misses EPS for Q4 2023
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.